Chuang Wang1, Neelam Tyagi1, Andreas Rimner1, Yu-Chi Hu1, Harini Veeraraghavan1, Guang Li1, Margie Hunt1, Gig Mageras1, Pengpeng Zhang2. 1. Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, USA; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. 2. Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, USA; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. Electronic address: zhangp@mskcc.org.
Abstract
PURPOSE: To design a deep learning algorithm that automatically delineates lung tumors seen on weekly magnetic resonance imaging (MRI) scans acquired during radiotherapy and facilitates the analysis of geometric tumor changes. METHODS: This longitudinal imaging study comprised 9 lung cancer patients who had 6-7 weekly T2-weighted MRI scans during radiotherapy. Tumors on all scans were manually contoured as the ground truth. Meanwhile, a patient-specific adaptive convolutional neural network (A-net) was developed to simulate the workflow of adaptive radiotherapy and to utilize past weekly MRI and tumor contours to segment tumors on the current weekly MRI. To augment the training data, each voxel inside the volume of interest was expanded to a 3 × 3 cm patch as the input, whereas the classification of the corresponding patch, background or tumor, was the output. Training was updated weekly to incorporate the latest MRI scan. For comparison, a population-based neural network was implemented, trained, and validated on the leave-one-out scheme. Both algorithms were evaluated by their precision, DICE coefficient, and root mean square surface distance between the manual and computerized segmentations. RESULTS: Training of A-net converged well within 2 h of computations on a computer cluster. A-net segmented the weekly MR with a precision, DICE, and root mean square surface distance of 0.81 ± 0.10, 0.82 ± 0.10, and 2.4 ± 1.4 mm, and outperformed the population-based algorithm with 0.63 ± 0.21, 0.64 ± 0.19, and 4.1 ± 3.0 mm, respectively. CONCLUSION: A-net can be feasibly integrated into the clinical workflow of a longitudinal imaging study and become a valuable tool to facilitate decision- making in adaptive radiotherapy.
PURPOSE: To design a deep learning algorithm that automatically delineates lung tumors seen on weekly magnetic resonance imaging (MRI) scans acquired during radiotherapy and facilitates the analysis of geometric tumor changes. METHODS: This longitudinal imaging study comprised 9 lung cancerpatients who had 6-7 weekly T2-weighted MRI scans during radiotherapy. Tumors on all scans were manually contoured as the ground truth. Meanwhile, a patient-specific adaptive convolutional neural network (A-net) was developed to simulate the workflow of adaptive radiotherapy and to utilize past weekly MRI and tumor contours to segment tumors on the current weekly MRI. To augment the training data, each voxel inside the volume of interest was expanded to a 3 × 3 cm patch as the input, whereas the classification of the corresponding patch, background or tumor, was the output. Training was updated weekly to incorporate the latest MRI scan. For comparison, a population-based neural network was implemented, trained, and validated on the leave-one-out scheme. Both algorithms were evaluated by their precision, DICE coefficient, and root mean square surface distance between the manual and computerized segmentations. RESULTS: Training of A-net converged well within 2 h of computations on a computer cluster. A-net segmented the weekly MR with a precision, DICE, and root mean square surface distance of 0.81 ± 0.10, 0.82 ± 0.10, and 2.4 ± 1.4 mm, and outperformed the population-based algorithm with 0.63 ± 0.21, 0.64 ± 0.19, and 4.1 ± 3.0 mm, respectively. CONCLUSION: A-net can be feasibly integrated into the clinical workflow of a longitudinal imaging study and become a valuable tool to facilitate decision- making in adaptive radiotherapy.
Authors: Pim Moeskops; Max A Viergever; Adrienne M Mendrik; Linda S de Vries; Manon J N L Benders; Ivana Isgum Journal: IEEE Trans Med Imaging Date: 2016-03-30 Impact factor: 10.048
Authors: Konstantinos Kamnitsas; Christian Ledig; Virginia F J Newcombe; Joanna P Simpson; Andrew D Kane; David K Menon; Daniel Rueckert; Ben Glocker Journal: Med Image Anal Date: 2016-10-29 Impact factor: 8.545
Authors: Stefano Trebeschi; Joost J M van Griethuysen; Doenja M J Lambregts; Max J Lahaye; Chintan Parmar; Frans C H Bakers; Nicky H G M Peters; Regina G H Beets-Tan; Hugo J W L Aerts Journal: Sci Rep Date: 2017-07-13 Impact factor: 4.379
Authors: Yan Liu; Strahinja Stojadinovic; Brian Hrycushko; Zabi Wardak; Steven Lau; Weiguo Lu; Yulong Yan; Steve B Jiang; Xin Zhen; Robert Timmerman; Lucien Nedzi; Xuejun Gu Journal: PLoS One Date: 2017-10-06 Impact factor: 3.240
Authors: Constance A Owens; Christine B Peterson; Chad Tang; Eugene J Koay; Wen Yu; Dennis S Mackin; Jing Li; Mohammad R Salehpour; David T Fuentes; Laurence E Court; Jinzhong Yang Journal: PLoS One Date: 2018-10-04 Impact factor: 3.240
Authors: Philipp Hoegen; Clemens Lang; Sati Akbaba; Peter Häring; Mona Splinter; Annette Miltner; Marion Bachmann; Christiane Stahl-Arnsberger; Thomas Brechter; Rami A El Shafie; Fabian Weykamp; Laila König; Jürgen Debus; Juliane Hörner-Rieber Journal: Front Oncol Date: 2020-12-09 Impact factor: 6.244
Authors: Danju Huang; Han Bai; Li Wang; Yu Hou; Lan Li; Yaoxiong Xia; Zhirui Yan; Wenrui Chen; Li Chang; Wenhui Li Journal: Technol Cancer Res Treat Date: 2021 Jan-Dec